These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 23945396)

  • 1. Back to the future: how human induced pluripotent stem cells will transform regenerative medicine.
    Svendsen CN
    Hum Mol Genet; 2013 Oct; 22(R1):R32-8. PubMed ID: 23945396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Breakthrough in research on pluripotent stem cells and their application in medicine].
    Valdimarsdóttir G; Richter A
    Laeknabladid; 2015 Dec; 101(12):581-6. PubMed ID: 26656400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promising new sources for pluripotent stem cells.
    Leeb C; Jurga M; McGuckin C; Moriggl R; Kenner L
    Stem Cell Rev Rep; 2010 Mar; 6(1):15-26. PubMed ID: 20091142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining Human Pluripotency.
    Yilmaz A; Benvenisty N
    Cell Stem Cell; 2019 Jul; 25(1):9-22. PubMed ID: 31271751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obstacles in Renal Regenerative Medicine: Metabolic and Epigenetic Parallels Between Cellular Reprogramming and Kidney Cancer Oncogenesis.
    Lichner Z; Mac-Way F; Yousef GM
    Eur Urol Focus; 2019 Mar; 5(2):250-261. PubMed ID: 28847686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Induced pluripotent stem cells: a new paradigm to study human tissues].
    Sansac C; Assou S; Bouckenheimer J; Lemaître JM; De Vos J
    Biol Aujourdhui; 2016; 210(1):1-8. PubMed ID: 27286575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical applications of patient-specific induced pluripotent stem cells in cardiovascular medicine.
    Oh Y; Wei H; Ma D; Sun X; Liew R
    Heart; 2012 Mar; 98(6):443-9. PubMed ID: 22285968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of induced pluripotent stem cells in research and therapy of primary immunodeficiencies.
    Weinacht KG; Brauer PM; Felgentreff K; Devine A; Gennery AR; Giliani S; Al-Herz W; Schambach A; Zúñiga-Pflücker JC; Notarangelo LD
    Curr Opin Immunol; 2012 Oct; 24(5):617-24. PubMed ID: 22841347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. iPS cell technology in regenerative medicine.
    Lengner CJ
    Ann N Y Acad Sci; 2010 Mar; 1192():38-44. PubMed ID: 20392216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspective: Why and How Ubiquitously Distributed, Vascular-Associated, Pluripotent Stem Cells in the Adult Body (vaPS Cells) Are the Next Generation of Medicine.
    Alt EU; Schmitz C; Bai X
    Cells; 2021 Sep; 10(9):. PubMed ID: 34571951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical potentials of human pluripotent stem cells.
    Mora C; Serzanti M; Consiglio A; Memo M; Dell'Era P
    Cell Biol Toxicol; 2017 Aug; 33(4):351-360. PubMed ID: 28176010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced pluripotent stem cells in regenerative medicine and disease modeling.
    Walmsley GG; Hyun J; McArdle A; Senarath-Yapa K; Hu MS; Chung MT; Wong VW; Longaker MT; Wan DC
    Curr Stem Cell Res Ther; 2014 Mar; 9(2):73-81. PubMed ID: 24359141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation and Application of Induced Pluripotent Stem Cell-Derived Vascular Smooth Muscle Cells.
    Maguire EM; Xiao Q; Xu Q
    Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2026-2037. PubMed ID: 28860223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of pluripotent stem cells for regenerative medicine.
    Li K; Kong Y; Zhang M; Xie F; Liu P; Xu S
    Biochem Biophys Res Commun; 2016 Feb; 471(1):1-4. PubMed ID: 26851367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical Modulation of Cell Fate in Stem Cell Therapeutics and Regenerative Medicine.
    Liu K; Yu C; Xie M; Li K; Ding S
    Cell Chem Biol; 2016 Aug; 23(8):893-916. PubMed ID: 27524294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future of iPS cells in advancing regenerative medicine.
    Liu P; Li KE; Xu S
    Genet Res (Camb); 2016 Feb; 98():e4. PubMed ID: 26864234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced pluripotent stem cells: current progress and potential for regenerative medicine.
    Amabile G; Meissner A
    Trends Mol Med; 2009 Feb; 15(2):59-68. PubMed ID: 19162546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Making it personal: the prospects for autologous pluripotent stem cell-derived therapies.
    Blair NF; Barker RA
    Regen Med; 2016 Jul; 11(5):423-5. PubMed ID: 27346669
    [No Abstract]   [Full Text] [Related]  

  • 19. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
    Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
    Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A "season of light" in stem cell research and regenerative medicine: observations on recent developments.
    Womack JE
    ILAR J; 2009; 51(1):85-7. PubMed ID: 20075501
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.